ARS:年度报告
04/27 03:15
PRE 14A:并购重组委托声明
04/23 04:37
10-K/A:年度报表(修正版)
04/23 04:32
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 8-K:重大事件
04/04 04:03
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 10-K:年度报表
03/28 18:49
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 8-K:肿瘤研究所公布2023年第四季度和全年财务业绩和2024年指导
03/28 04:10
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
01/31 08:08
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
01/27 08:20
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
01/23 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 144:拟议出售证券
01/19 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | SC 13D/A:超过5%持股股东披露文件(修正)-Havencrest Healthcare Partners GP, LLC(12.04%),Havencrest Healthcare Partners, L.P.(11.93%)等
01/02 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
01/02 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 BARASCH RICHARD A
2023/12/28 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Hively Brad
2023/12/28 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Johnson Karen Marie
2023/12/28 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Kaushal Mohit
2023/12/28 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Ling Gabriel
2023/12/28 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 McGeorge Anne
2023/12/28 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 O'Meara Maeve
2023/12/28 13:00
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Pacala Mark L
2023/12/28 13:00
暂无数据
暂无数据